HUT50035A - Process for producing pharmaceutical compositions comprising solid ethophenamate, particularly for oral and rectal application - Google Patents

Process for producing pharmaceutical compositions comprising solid ethophenamate, particularly for oral and rectal application

Info

Publication number
HUT50035A
HUT50035A HU891392A HU139289A HUT50035A HU T50035 A HUT50035 A HU T50035A HU 891392 A HU891392 A HU 891392A HU 139289 A HU139289 A HU 139289A HU T50035 A HUT50035 A HU T50035A
Authority
HU
Hungary
Prior art keywords
ethophenamate
oral
solid
pharmaceutical compositions
producing pharmaceutical
Prior art date
Application number
HU891392A
Other languages
English (en)
Inventor
Erich Horvath
Original Assignee
Hexal Pharma Gmbh Und Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Pharma Gmbh Und Co Kg filed Critical Hexal Pharma Gmbh Und Co Kg
Publication of HUT50035A publication Critical patent/HUT50035A/hu

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU891392A 1988-03-23 1989-03-22 Process for producing pharmaceutical compositions comprising solid ethophenamate, particularly for oral and rectal application HUT50035A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3809808A DE3809808A1 (de) 1988-03-23 1988-03-23 Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
HUT50035A true HUT50035A (en) 1989-12-28

Family

ID=6350496

Family Applications (1)

Application Number Title Priority Date Filing Date
HU891392A HUT50035A (en) 1988-03-23 1989-03-22 Process for producing pharmaceutical compositions comprising solid ethophenamate, particularly for oral and rectal application

Country Status (6)

Country Link
EP (1) EP0334218A1 (hu)
JP (1) JPH0222224A (hu)
DE (1) DE3809808A1 (hu)
DK (1) DK141789A (hu)
HU (1) HUT50035A (hu)
PT (1) PT90093A (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04100347A (ja) * 1990-08-18 1992-04-02 Mitsubishi Electric Corp Ａｔｍ伝送方式
JP4746941B2 (ja) * 2005-08-29 2011-08-10 和泉薬品工業株式会社 素錠とコーティング層からなる丸剤または錠剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5738569B2 (hu) * 1974-03-27 1982-08-16
US4073231A (en) * 1976-11-29 1978-02-14 Weber Marking Systems, Inc. Selective label printer
DE2746087A1 (de) * 1977-10-13 1979-04-26 Chinoin Gyogyszer Es Vegyeszet Cyclodextrin-einschlusskomplexe mit indomethacin, verfahren zu ihrer herstellung und pharmazeutische mittel
HU176215B (en) * 1978-01-27 1981-01-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1
HU180183B (en) * 1980-12-19 1983-02-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing stable suppository compositions containing volatile and/or labile active substances
HU183408B (en) * 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
DE3337802A1 (de) * 1983-10-18 1985-04-25 Merck Patent Gmbh, 6100 Darmstadt Pharmazeutische zubereitung
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4616008A (en) * 1984-05-02 1986-10-07 Takeda Chemical Industries, Ltd. Antibacterial solid composition for oral administration
DE3427787A1 (de) * 1984-07-27 1986-01-30 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Wirkstoffkomplexe von 5-methoxy-2((4-methoxy-3,5-dimethyl-2-pyridyl) methylsulfinyl)-1h-benzimidazol mit cyclodextrinen, deren herstellung und arzneimittel
HU199444B (en) * 1985-09-10 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom

Also Published As

Publication number Publication date
PT90093A (pt) 1989-11-10
DE3809808A1 (de) 1989-10-05
DK141789A (da) 1989-09-24
EP0334218A1 (de) 1989-09-27
DK141789D0 (da) 1989-03-22
JPH0222224A (ja) 1990-01-25

Similar Documents

Publication Publication Date Title
HUT53362A (en) Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same
HU9303252D0 (en) New thiopyrano-pyrrole derivatives, pharmaceutical compositions containing them and process for producing them
EG19242A (en) Process for preparing oral compositions.
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
HUT50036A (en) Process for producing new ranitidine derivatives and pharmaceutical compositions comprising same
HUT49366A (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same
HUT63628A (en) Process for producing new cefalosporing derivatives and pharmaceutical compositions comprising same
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUT48624A (en) Process for producing 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions comprising such compounds
HUT47103A (en) Process for producing 1,4-benzoxazine derivatives and pharmaceutical compositions comprising the same
HUT57237A (en) Process for producing glucosaminoglucanic salts and pharmaceutical compositions comprising same
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
HUT47113A (en) Process for producing 3-(benzopyrano- and -thiopyrano-pyrazolyl)-3-oxo-propionitriles and pharmaceutical compositions comprising the same
HUT51265A (en) Process for producing cyclohexane derivatives and pharmaceutical compositions comprising same
HUT51268A (en) Process for producing isoindoline derivatives and pharmaceutical compositions comprising same
HUT48870A (en) Process for producing aminoalkoxyphenyl derivatives and pharmaceutical compositions comprising same
HUT49871A (en) Process for producing indolylpiperidine derivatives and pharmaceutical compositions comprising same
HUT53625A (en) Process for producing 2-iminobenzothiazole derivatives and pharmaceutical compositions comprising same
HUT48869A (en) Process for producing indan derivatives and pharmaceutical compositions comprising same
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
HUT46644A (en) Process for producing propylophenone derivatives and pharmaceutical compositions comprising the same
HU9400934D0 (en) Thiadiazinone derivatives, pharmaceutical compositions containing them and process for producing them
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
HUT53620A (en) Process for producing new thiouracyl derivatives and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
DFC9 Refusal of application